Related Experiment Video
Updated: Jun 23, 2026
09:33
Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
Published on: June 2, 2018
Generating mESC-derived insulin-producing cell lines through an intermediate lineage-restricted progenitor line
GuoDong Li1, Ruihua Luo, Jiping Zhang
1Cardiovascular Research Institute, National University Medical Institutes, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. nmiligd@nus.edu.sg
Stem Cell Research
|April 23, 2009
Summary
Researchers developed a new method to create insulin-producing cells from mouse embryonic stem cells (ESCs). This protocol yields scalable, stable cell lines that successfully reverse hyperglycemia in mice, offering a promising advancement for diabetes research.
Area of Science:
- Stem Cell Biology
- Endocrinology
- Developmental Biology
Background:
- Generating functional insulin-producing cells from stem cells for diabetes therapy remains a significant challenge.
- Existing methods often result in heterogeneous cell populations with limited scalability.
Purpose of the Study:
- To develop a reproducible protocol for generating homogeneous and scalable insulin-producing cell lines from mouse embryonic stem cells (mESCs).
- To characterize these derived cell lines for their potential as a therapeutic source for diabetes.
Main Methods:
- Differentiation of lineage-restricted mESC-derived E-RoSH cells under nutrient-depleted conditions with nicotinamide.
- Isolation and cloning of insulin-producing cell lines using limiting dilution.
- Characterization of cell lines for genomic, structural, biochemical, and pharmacological properties of pancreatic beta cells.
- In vivo transplantation studies in streptozotocin-treated SCID mice.
Main Results:
- A novel protocol successfully generated stable, homogeneous insulin-producing cell lines from mESC-derived E-RoSH cells.
- The derived cell lines exhibited key characteristics of pancreatic beta cells, including glucose-sensitive insulin secretion.
- Transplanted cells reversed hyperglycemia in mice without teratoma formation.
Conclusions:
- This study presents a robust and scalable method for generating functional, transplantable insulin-producing cells from ESCs.
- The established cell lines hold significant potential for future cell-based therapies for type 1 diabetes.
